- Advertisement -
Image source: Getty Images
The Mesoblast Limited (ASX: MSB) share price is heading north today following a positive update regarding its remestemcel-L drug.
At the time of writing, the share price of the allogeneic cellular medicines company is up by 2.94% to $1.40….
